NYSE: HQL - Tekla Life Sciences Investors

Lønnsomhet i seks måneder: -16.6%
Utbytte: +12.58%
Sektor: Financials

Kampanjeplan Tekla Life Sciences Investors

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies.

flere detaljer
It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 1992-05-04
ISIN US87911K1007
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 17.34
Дивиденд ао 2.33
Сайт https://www.teklacap.com/hql.html
Цена ао 12.98
Prisendring per dag: -0.1541% (12.98)
Prisendring per uke: -1.97% (13.22)
Prisendring per måned: -6.09% (13.8)
Prisendring over 3 måneder: -6.36% (13.84)
Prisendring over seks måneder: -16.6% (15.54)
Prisendring per år: -3.93% (13.49)
Prisendring over 3 år: -18.59% (15.92)
Prisendring over 5 år: -27.27% (17.82)
Prisendring over 10 år: 0% (12.96)
Prisendring siden begynnelsen av året: -4% (13.5)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 4.88 3
P/BV 0.9204 9
P/E 4.96 10
EV/EBITDA 14.85 7
Total: 8.63

Effektivitet

Navn Betydning Karakter
ROA, % 19.76 6
ROE, % 19.8 6
Total: 5.17

Utbytte

Navn Betydning Karakter
Div yield, % 12.58 10
DSI 0.8571 8.57
Total: 7.58

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -30.15 0
Lønnsomhet Ebitda, % -131.71 0
Lønnsomhet EPS, % -41.09 0
Total: 0
Flere detaljer

Flere detaljer

Institusjoner Volum Dele, %
Saba Capital Management, L.P. 1421300 5.42
Cornerstone Advisors, LLC 494340 1.89
1607 Capital Partners, LLC 480179 1.83
Allspring Global Investments Holdings, LLC 454154 1.73
Morgan Stanley 430266 1.64
AQR Arbitrage LLC 384231 1.47
Clough Capital Partners, LP 375410 1.43
RPO LLC 338542 1.29
Needham Investment Management, L.L.C. 313792 1.2
Flagship Harbor Advisors, LLC 264003 1.01

ETFDele, %Lønnsomhet for året, %Utbytte, %
Saba Closed End Funds ETF 2.8917 17.31 2.29022
Amplify High Income ETF 2.263 6.94 2.77149
First Trust Income Opportunities ETF 0.4681 18.3 2.48805
1.8714.182.52



Veileder Stillingstittel Betaling Fødselsår
Dr. Daniel R. Omstead M.S, Ph.D. Principal Executive Officer, President and Trustee N/A 1953 (72 år)
Mr. Peter Branner Chief Investment Officer N/A 1964 (61 år)

Adresse: United States, Boston. MA, 100 Federal Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.teklacap.com/hql.html